Feb 09 2021 Read 664 Times
Are you interested in learning about three different pipe::scan applications in three countries? During this webinar you will learn from our experienced guest speakers where and how they are using pipe::scan systems, which challenges they faced and which benefits they gain from using a smart water quality monitoring solution. At the end of the session you will have a chance to ask questions that might occur during the webinar.
Presenters: Benjamin Buysschaert, FARYS - Belgium; Jordi Raich, s::can Iberia – Spain; Philipp Proksch, University of Natural Resources and Life Sciences - Austria
Date: February 11, 2021, 3 - 4 pm CET
E-Mail
Modern immunotherapeutic anti-cancer drugs support a natural mechanism of the immune system to inhibit the growth of cancer cells. They dock onto a specific receptor of the killer cell and prevent it from being switched off by the cancer cells. This is a complex molecular process, which is known but has not yet been fully understood. In a molecular dynamics study conducted by the group led by medical information scientist Wolfgang Schreiner and gynaecologists Heinz Kölbl and Georg Pfeiler from MedUni Vienna, working with biosimulation expert Chris Oostenbrink from the University of Natural Resources and Applied Life Sciences (Boku) Vienna, has now, for the first time, analysed this mechanism for the drugs nivolumab and pembrolizumab. It was found that tiny molecular motions are of key significance. The study has been published in the leading journal
Tuesday, 29 Dec 2020 03:53 PM MYT
Walter Gruell, fish farmer and fish delicacy store owner, presents his products including a white caviar (blue box) at his store in the village of Anif near Salzburg, Austria, n December 15, 2020. AFP pic
Subscribe to our Telegram channel for the latest updates on news you need to know.
GRODIG, Dec 29 In his waders, Stefan Astner checks on the albino sturgeon: Almost two decades after they hatched, they re ready to be gutted for their caviar to be shipped out for New Year s celebrations.
“The fish have already been through the ultrasound so we saw that they are full (of roe) and they will go into production soon,” Astner says, dipping his net into a small pond teeming with the rare, white sturgeon.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Avalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Expand .
Avalon GloboCare Corp.December 30, 2020 GMT
Aiming to accelerate the clinical development of S-layer nanotechnology for mucosal vaccines, hemo-filtration devices, cell-based therapies and other medical applications
Establishing state-of-the-art research facility at the University of Natural Resources and Life Sciences (BOKU) in Vienna, Austria, led by the developers and leading world experts on S-layer technology
Forming alliances with premiere biomedical research centers across Europe Avalon’s scientific capabilities featured in December 2020 issue of
Nature Biopharma Dealmakers